Would you invest in a startup developing a cardiovascular surgical device? If yes, you’re not alone: It’s been the most active category for medtech investment in 2023 year to date, with $487.7 million in VC funding in Q3 alone. Cancer diagnostics and surgical robotics have also been locking up major dollars, according to PitchBook’s Q3 2023 Medtech Report. Leading the pack are names such as Neuralink and Beta Bionics, both of which closed nine-figure deals in late Q3, setting the stage for a strong finish for the year.
Read the full article: PitchBook Q3 2023 Medtech Report //
Source: https://pitchbook.com/news/reports/q3-2023-medtech-report